Loading...
XETR
MAK
Market cap23mUSD
Jul 09, Last price  
0.96EUR
1D
5.49%
1Q
-15.79%
Jan 2017
-23.81%
Name

MATERNUS-Kliniken AG

Chart & Performance

D1W1MN
XETR:MAK chart
P/E
—
P/S
0.17
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
0.64%
Revenues
118m
+3.51%
106,405,000109,812,000112,797,000111,811,000110,904,000113,942,000113,566,000122,041,000123,269,000124,040,000127,143,000124,278,000124,430,000114,299,000111,437,000106,697,000102,306,000114,004,000118,000,000
Net income
-14m
L+5.65%
-4,277,000-2,742,000886,0001,979,000-1,888,000-8,599,000-12,725,00026,844,0002,358,0001,104,000-1,456,000-1,575,000-10,256,000-9,622,000-2,561,000-14,077,000-14,257,000-13,157,000-13,900,000
CFO
14m
-6.93%
3,802,000-5,103,0003,228,0001,853,0005,546,0004,382,0003,068,00011,303,000-2,906,0007,902,0009,529,0006,234,00016,030,00012,167,00017,244,0004,329,0002,524,00015,074,00014,030,000
Dividend
Aug 31, 20000.38 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Maternus-Kliniken AG oversees a network of facilities that includes retirement and nursing residences, rehabilitation centers, and a variety of specialized service companies. This enterprise primarily focuses on delivering geriatric care and medical rehabilitation services. Furthermore, it offers an extensive range of support options, such as emergency response systems, assisted living arrangements, and various care modalities including home care, residential care, temporary stays, and care for individuals with disabilities. Its services also encompass comprehensive rehabilitation and post-treatment programs. The company maintains roughly 23 establishments throughout Germany. Founded in 1877, Maternus-Kliniken AG's corporate headquarters are situated in Berlin, Germany.
URL
https://www.maternus.de/
IPO date
Apr 02, 1997
Employees
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT